| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-07 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |